CDEK
← All drugs Report issue

COVID-19 convalescent plasma

Biologicalexperimental

Clinical trial activity

181 trials · 312 clinical orgs · 0 marketing orgs

Phase 1
38
Phase 2
104
Phase 3
48
Phase 4
0

Earliest trial started Feb 28, 2015 (NCT02342171)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • SARS-CoV-2Immunity, passive

    SARS-CoV-2 immunity, passive

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07094087Phase 3Sep 10, 2025CSL Behring
NCT07032792Phase 2Jun 30, 2025Northwell Health
NCT05904067N/AJun 10, 2023China Academy of Chinese Medical Sciences
NCT05648110Phase 3Dec 30, 2022AstraZeneca
NCT05438498Phase 3Jun 3, 2022MediMergent, LLC
NCT05271929Phase 3Apr 1, 2022CHU Besançon, Erasmus University Rotterdam, German Red Cross, NHS Blood and Transplant, University of Oxford
NCT05281601Phase 1Mar 21, 2022AstraZeneca
NCT05184062Phase 2Dec 3, 2021AstraZeneca
NCT05166421Phase 1Nov 30, 2021AstraZeneca
NCT05077930Phase 2Oct 31, 2021Centro de Hematologia e Hemoterapia do Paraná - Hemepar, Federal University of Bahia, HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO, SEVILLA, Science Valley Research Institute
NCT05437289Phase 1Oct 9, 2021AstraZeneca
NCT04910269Phase 3Aug 6, 2021International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), University of Minnesota
NCT04913779Phase 2/Phase 3 (Phase 3)Jun 1, 2021Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran, Government of Argentina
NCT04644198Phase 2Jun 1, 2021University of The West Indies
NCT04834089Phase 1/Phase 2 (Phase 2)May 31, 2021Butantan Institute
NCT04836260Phase 3Apr 8, 2021HFR-Fribourg Hôpital Cantonal, Hôpital Fribourgeois, Klinik Infektiologie & Spitalhygiene, Ospedale Regionale di Lugano, University of Basel, University of Geneva
NCT05780437Phase 3Feb 5, 2021AIDS Clinical Trials Group, AstraZeneca, Cardiothoracic Surgical Trials Network, Department of Veteran Affairs, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), Medical Research Council, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), University of Copenhagen, University of Minnesota, University of New South Wales
NCT04723394Phase 3Jan 28, 2021AstraZeneca
NCT04730401Phase 2Jan 27, 2021Finnish Red Cross, University of Helsinki
NCT04712344Phase 2Jan 18, 2021University of Erlangen-Nuremberg
Showing 20 of 181 trials
Page 1 / 10

Organizations

Research & Development (312)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AstraZenecaFor profit10932020
Johns Hopkins UniversityAcademic/Hospital5322020
National Institute of Allergy and Infectious Diseases (NIAID)Government4122020
Danderyds HospitalAcademic/Hospital3022020
Erasmus University RotterdamAcademic/Hospital3212020
Hackensack University Medical CenterAcademic/Hospital3322020
Karolinska InstituteAcademic/Hospital3322020
National Institutes of Health (NIH)Government3022020
University of MinnesotaAcademic/Hospital3212020
University of OxfordAcademic/Hospital3112015
Ain Shams UniversityAcademic/Hospital2222020
Azienda Socio Sanitaria Territoriale di MantovaAcademic/Hospital2222020
Centro de Educación Medica e Investigaciones Clínicas Norberto QuirnoAcademic/Hospital2122020
Columbia UniversityAcademic/Hospital2212020
Cornell UniversityAcademic/Hospital2112020
Department of Veteran AffairsGovernment2112020
D'Or Institute for Research and EducationAcademic/Hospital2212020
Eijkman Institute for Molecular Biology, Jakarta, IndonesiaAcademic/Hospital2022020
Etablissement Français du SangAcademic/Hospital2022015
Foundation IRCCS San Matteo HospitalAcademic/Hospital2212020
312 organizations
Page 1 / 16